Fiberless recombinant adenoviruses: Virus maturation and infectivity in the absence of fiber

Journal of Virology

Volumn 73, Issue 2, 1999, Pages 907-919

  Legrand, V ^b   Spehner, D ^a   Schlesinger, Y ^b   Settelen, N ^b   Pavirani, A ^b   Mehtali, M ^b  

^a INSERM   (France)

^b TRANSGENE S A   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; GENE TRANSFER; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS ASSEMBLY; VIRUS GENE; VIRUS INFECTIVITY; VIRUS RECOMBINANT;

EID: 0032925670     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.2.907-919.1999     Document Type: Article

References (65)

1. Akusjärvi, G., and G. Wadell. 1987. Genetic maps of human and animal adenoviruses, p. 78-85. In S. J. O'Brien (ed.), Genetic maps 1987, a compilation of linkage and restriction maps of genetically studied organisms, vol. 4. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
2. Albelda, S. M., S. A. Mette, D. E. Elder, R. Stewart, L. Damjanovich, M. Herlyn, and C. A. Buck. 1990. Integrin distribution in malignant melanoma: association of the β3 subunit with tumor progression. Cancer Res. 50:6757-6764.
3. Arcosoy, S. M., J. D. Latoche, M. Gondor, B. R. Pitt, and J. M. Pilewski. 1997. Polycations increase the efficiency of adenovirus-mediated gene transfer to epithelial and endothelial cells in vitro. Gene Ther. 4:32-38.
4. Assoian, R., and E. Marcantonio. 1997. The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis. J. Clin. Invest. 100: S15-S18.
5. Bergelson, J. M., J. A. Cunningham, G. Droguett, E. A. Kurt-Jones, A. Krithivas, J. S. Hong, M. S. Horwitz, R. L. Crowell, and R. W. Finberg. 1997. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323.
6. Bramson, J., F. Graham, and J. Gauldie. 1995. The use of adenoviral vectors for gene therapy and gene transfer in vivo. Curr. Opin. Biotechnol. 6:590-595.
7. Bui, L. A., L. H. Butterfield, J. Y. Kim, A. Ribas, P. Seu, R. Lau, J. A. Glaspy, W. H. McBride, and J. S. Economou. 1997. In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2. Hum. Gene Ther. 8:2173-2182.
8. Cagnon, C., V. Valverde, and J. Masson. 1991. A new family of sugar-inducible expression vectors for Escherichia coli. Prot. Eng. 4:843-847.
9. Chartier, C., E. Degryse, M. Gantzer, A. Dieterle, A. Pavirani, and M. Mehtali. 1996. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70:4805-4810.
10. Chroboczek, J., F. Bieber, and B. Jacrot. 1992. The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2. Virology 186:280-285.
11. Cotten, M., and J. M. Weber. 1995. The adenovirus protease is required for virus entry into host cells. Virology 213:494-502.
12. Crompton, J., C. I. Toogood, N. Wallis, and R. T. Hay. 1994. Expression of a foreign epitope on the surface of the adenovirus hexon. J. Gen. Virol. 75:133-139.
13. Crystal, R. G. 1995. Transfer of genes to humans: early lessons and obstacles to success. Science 270:404-410.
14. Defer, C., M.-T. Belin, M.-L. Caillet-Boudin, and P. Boulanger. 1990. Human adenovirus-host cell interactions: comparative study with members of subgroups B and C. J. Virol. 64:3661-3673.
15. D'Halluin, J.-C. 1995. Virus assembly, p. 47-66. In W. Doerfler and P. Böhm (ed.), The molecular repertoire of adenoviruses I - virion structure and infection. Springer-Verlag, Berlin, Germany.
16. Douglas, J., B. Rogers, M. Rosenfeld, S. Michael, M. Feng, and D. Curiel. 1996. Targeted gene delivery by tropism-modified adenoviral vectors. Nat. Biotechnol. 14:1574-1578.
17. Falgout, B., and G. Ketner. 1987. Adenovirus early region 4 is required for efficient virus particle assembly. J. Virol. 61:3759-3768.
18. Falgout, B., and G. Ketner. 1988. Characterization of adenovirus particles made by deletion mutants lacking the fiber gene. J. Virol. 62:622-625.
19. Gladson, C. L., and D. A. Cheresh. 1991. Glioblastoma expression of vitronectin and the αvβ3 integrin: adhesion mechanism for transformed glial cells. J. Clin. Invest. 88:1924-1932.
20. Gluzman, Y., and K. van Doren. 1983. Palindromic adenovirus type 5-simian virus 40 hybrid. J. Virol. 45:91-103.
21. Goldman, C. K., B. E. Rogers, J. T. Douglas, B. A. Sosnowski, W. B. Ying, G. P. Siegal, A. Baird, J. A. Campain, and D. T. Curiel. 1997. Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor. Cancer Res. 57:1447-1451.
22. Goodman, J., T. Trask, S.-H. Chen, S. Woo, R. Grossman, K. Carey, G. Hubbard, D. Carrier, S. Rajagopalan, E. Aguilar-Cordova, and H. Shine. 1996. Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: pathologic, radiologic, and molecular studies. Hum. Gen. Ther. 7:1241-1250.
23. Gough, J., and N. Murray. 1983. Sequence diversity among related genes for recognition of specific targets in DNA molecules. J. Mol. Biol. 166:1-19.
24. Graham, F., and L. Prevec. 1991. Manipulation of adenovirus vectors. Methods Mol. Biol. 7:109-128.
25. Graham, F., J. Smiley, W. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human Ad5. J. Gen. Virol. 75:133-139.
26. Graham, F., and A. Van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
27. Greber, U. F., P. Webster, J. Weber, and A. Helenius. 1996. The role of the adenovirus protease in virus entry into cells. EMBO J. 15:1766-1777.
28. Henry, L., D. Xia, M. Wilke, J. Deisenhofer, and R. Gerard. 1994. Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli. J. Virol. 68:5239-5246.
29. Hong, J., and J. Engler. 1996. Domains required for assembly of adenovirus type 2 fibers trimers. J. Virol. 70:7071-7078.
30. Hong, S. S., L. Karayan, J. Tournier, D. T. Curiel, and P. A. Boulanger. 1997. Adenovirus type 5 fiber knob binds to MHC class I α2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J. 16:2294-2306.
31. Huang, S., T. Kamata, Y. Takada, Z. Ruggeri, and G. Nemerow. 1996. Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J. Virol. 70:4502-4508.
32. Kovesdi, I., D. E. Brough, J. T. Bruder, and T. J. Wickham. 1997. Adenoviral vectors for gene transfer. Curr. Opin. Biotechnol. 8:583-589.
33. Kozak, M. 1986. Influences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc. Natl. Acad. Sci. USA 83:2850-2854.
34. Krasnykh, V., I. Dmitriev, G. Mekheeva, C. R. Miller, N. Belousova, and D. T. Curiel. 1998. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J. Virol. 72:1844-1852.
35. Krasnykh, V., G. Mikheeva, J. Douglas, and D. Curiel. 1996. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J. Virol. 70:6839-6846.
36. Louis, N., P. Fender, A. Barge, P. Kitts, and J. Chroboczek. 1994. Cell binding domain of adenovirus serotype 2 fiber. J. Virol. 68:4104-4106.
37. Lusky, M., M. Christ, K. Rittner, A. Dieterle, D. Dreyer, B. Mourot, H. Schutz, F. Stoeckel, A. Pavirani, and M. Mehtali. 1998. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. J. Virol. 72:2022-2032.
38. Lutz, P., and C. Kedinger. 1996. Properties of the adenovirus Iva2 gene product, an effector of late-phase-dependent activation of the major late promoter. J. Virol. 70:1396-1405.
39. Lutz, P., M. Rosa-Calatrava, and C. Kedinger. 1997. The product of the adenovirus intermediate gene IX is a transcriptional activator. J. Virol. 71:5102-5109.
40. Marcel, T., and J. D. Grausz. 1997. The TMC worldwide gene therapy enrollment report, end 1996. Hum. Gen. Ther. 8:775-800.
41. Mathias, P., T. Wickham, M. Moore, and G. Nemerow. 1994. Multiple adenovirus serotypes use αv integrins for infection. J. Virol. 68:6811-6814.
42. Max, R., R. R. Gerritsen, P. T. Nooijen, S. L. Goodman, A. Sutter, U. Keilholz, D. J. Ruiler, and R. M. De Waal. 1997. Immunohistochemical analysis of αvβ3 expression on tumor-associated vessels of human carcinomas. Int. J. Cancer 71:320-324.
43. Michael, S., J. Hong, D. Curiel, and J. Engler. 1995. Addition of a short ligand peptide to the adenovirus fiber protein. Gene Ther. 2:660-668.
44. Novelli, A., and P. Boulanger. 1991. Deletion analysis of functional domains in baculovirus-expressed adenovirus type 2 fiber. Virology 185:365-376.
45. Philipson, L., K. Lonberg-Holm, and U. Pettersson. 1968. Virus-receptor interaction in an adenovirus system. J. Virol. 2:1064-1075.
46. Sambrook, J., E. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
47. Sanes, J., J. Rubenstein, and J. Nicolas. 1986. Use of a retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 5:3133-3142.
48. Santis, G., V. Legrand, S. S. Hong, E. Davison, I. Kirby, J.-L. Imler, R. W. Finberg, J. M. Bergelson, M. Mehtali, and P. Boulanger. Molecular determinants and serotype specificity of adenovirus fiber binding to its high affinity receptors CAR. Submitted for publication.
49. Slos, P., D. Speck, N. Accart, H. Kolbe, D. Schubnel, B. Bouchon, R. Bishoff, and M.-P. Kieny. 1994. Recombinant cholera toxin B in Escherichia coli: high level secretion, purification and characterization. Prot. Expr. Purif. 5:518-526.
50. Spehner, D., A. Kirn, and R. Drillien. 1991. Assembly of nucleocapsid-like structures in animal cells infected with a vaccinia virus recombinant encoding the measles virus nucleoprotein. J. Virol. 65:6296-6300.
51. Stevenson, S., M. Rollence, B. White, L. Weaver, and A. McLelland. 1995. Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain. J. Virol. 69:2850-2857.
52. Stevenson, S. C., M. Rollence, J. Marshall-Neff, and A. McClelland. 1997. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. J. Virol. 71:4782-4790.
53. Stouffer, G. A., Z. Hu, M. Sajid, H. Li, G. Jin, M. T. Nakada, S. R. Hanson, and M. S. Runge. 1998. β3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells. Circulation 97:907-915.
54. Stratford-Perricaudet, L., I. Makeh, M. Perricaudet, and P. Briand. 1992. Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90:626-630.
55. Tomko, R. P., R. Xu, and L. Philipson. 1997. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. USA 94:3352-3356.
56. Von Seggern, D. J., J. Kehler, R. I. Endo, and G. R. Newerow. 1998. Complementation of a fiber adenovirus mutant by packaging cell lines expressing the adenovirus type 5 fiber protein. Virology 79:1461-1468.
57. Watkins, S. J., V. V. Mesyanzhinov, L. P. Kurochkina, and R. E. Hawkins. 1997. The 'adenobody' approach to viral targeting: specific and enhanced adenoviral gene delivery. Gene Ther. 4:1004-1012.
58. Weber, J. M. 1995. Adenovirus endopeptidase and its role in virus infection, p. 227-235. In W. Doerfler and P. Böhm (ed.), The molecular repertoire of adenoviruses I - virion structure and infection. Springer-Verlag, Berlin, Germany.
59. 5 promote adenovirus internalization but not virus attachment. Cell 73:309-319.
60. Wickham, T., P. Roelvink, D. Brough, and I. Kovesdi. 1996. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nat. Biotechnol. 14:1570-1573.
61. Wickham, T., D. Segal, P. Roelvink, M. Carrion, A. Lizonova, G. Lee, and I. Kovesdi. 1996. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J. Virol. 70:6831-6838.
62. Wickham, T. J., M. E. Carrion, and I. Kovesdi. 1995. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther. 2:750-756.
63. Wickham, T. J., G. M. Lee, J. A. Titus, G. Sconocchia, T. Bakacs, I. Kovesdi, and D. M. Segal. 1997. Targeted adenovirus-mediated gene delivery to T cells via CD3. J. Virol. 71:7663-7669.
64. Wickham, T. J., E. Tzeng, L. L. Shears II, P. W. Roelvink, Y. II, G. M. Lee, D. E. Brough, A. Lizonova, and I. Kovesdi. 1997. Increased in vitro and in vivo gene transfer by adenovirus containing chimeric fiber proteins. J. Virol. 71:8221-8229.
65. Yee, D., S. McGuire, N. Brünner, T. Kovelsky, D. Allred, S. Chen, and S. Woo. 1996. Adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase in an ascites model of human breast cancer. Hum. Gene Ther. 7:1251-1257.